Hypelcin B-I
| Internal ID | 01742368-6af4-4a86-85b5-64948b8ee3e7 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (4S)-4-[[2-[[2-[[2-[[(2S)-1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[[1-(2-acetamido-2-methylpropanoyl)pyrrolidine-2-carbonyl]amino]-2-methylpropanoyl]amino]propanoylamino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-[[(2S)-5-amino-1-[[(2S)-1-hydroxy-4-methylpentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxopentanoic acid |
| SMILES (Canonical) | CC(C)CC(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C(C)C)NC(=O)C1CCCN1C(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)CNC(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C2CCCN2C(=O)C(C)(C)NC(=O)C |
| SMILES (Isomeric) | CC(C)C[C@@H](CO)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C(C)C)NC(=O)[C@@H]1CCCN1C(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)CNC(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C2CCCN2C(=O)C(C)(C)NC(=O)C |
| InChI | InChI=1S/C89H152N22O25/c1-45(2)41-50(44-112)94-63(120)51(33-36-57(90)114)95-64(121)52(35-38-60(117)118)96-73(130)83(15,16)108-77(134)87(23,24)106-69(126)61(47(5)6)99-67(124)55-31-29-39-110(55)79(136)89(27,28)109-75(132)85(19,20)101-59(116)43-92-70(127)80(9,10)104-66(123)54(42-46(3)4)98-72(129)82(13,14)103-65(122)53(34-37-58(91)115)97-74(131)84(17,18)107-76(133)86(21,22)102-62(119)48(7)93-71(128)81(11,12)105-68(125)56-32-30-40-111(56)78(135)88(25,26)100-49(8)113/h45-48,50-56,61,112H,29-44H2,1-28H3,(H2,90,114)(H2,91,115)(H,92,127)(H,93,128)(H,94,120)(H,95,121)(H,96,130)(H,97,131)(H,98,129)(H,99,124)(H,100,113)(H,101,116)(H,102,119)(H,103,122)(H,104,123)(H,105,125)(H,106,126)(H,107,133)(H,108,134)(H,109,132)(H,117,118)/t48?,50-,51-,52-,53?,54?,55-,56?,61?/m0/s1 |
| InChI Key | NBKNEPZRLHROFK-VGPOKWSDSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C89H152N22O25 |
| Molecular Weight | 1930.30 g/mol |
| Exact Mass | 1929.12989842 g/mol |
| Topological Polar Surface Area (TPSA) | 708.00 Ų |
| XlogP | -2.70 |
| Atomic LogP (AlogP) | -4.40 |
| H-Bond Acceptor | 24 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 52 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5562 | 55.62% |
| Caco-2 | - | 0.8581 | 85.81% |
| Blood Brain Barrier | - | 0.6000 | 60.00% |
| Human oral bioavailability | - | 0.5714 | 57.14% |
| Subcellular localzation | Lysosomes | 0.6423 | 64.23% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8523 | 85.23% |
| OATP1B3 inhibitior | + | 0.9416 | 94.16% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9293 | 92.93% |
| P-glycoprotein inhibitior | + | 0.7420 | 74.20% |
| P-glycoprotein substrate | + | 0.8601 | 86.01% |
| CYP3A4 substrate | + | 0.7343 | 73.43% |
| CYP2C9 substrate | + | 0.6054 | 60.54% |
| CYP2D6 substrate | - | 0.8657 | 86.57% |
| CYP3A4 inhibition | - | 0.7194 | 71.94% |
| CYP2C9 inhibition | - | 0.9005 | 90.05% |
| CYP2C19 inhibition | - | 0.7386 | 73.86% |
| CYP2D6 inhibition | - | 0.9039 | 90.39% |
| CYP1A2 inhibition | - | 0.8859 | 88.59% |
| CYP2C8 inhibition | + | 0.6479 | 64.79% |
| CYP inhibitory promiscuity | - | 0.9704 | 97.04% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.7800 | 78.00% |
| Carcinogenicity (trinary) | Non-required | 0.5915 | 59.15% |
| Eye corrosion | - | 0.9824 | 98.24% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7874 | 78.74% |
| Skin corrosion | - | 0.8958 | 89.58% |
| Ames mutagenesis | - | 0.7100 | 71.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6896 | 68.96% |
| Micronuclear | + | 0.5800 | 58.00% |
| Hepatotoxicity | + | 0.5282 | 52.82% |
| skin sensitisation | - | 0.8772 | 87.72% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.7889 | 78.89% |
| Mitochondrial toxicity | + | 0.6875 | 68.75% |
| Nephrotoxicity | - | 0.6868 | 68.68% |
| Acute Oral Toxicity (c) | III | 0.6408 | 64.08% |
| Estrogen receptor binding | - | 0.5657 | 56.57% |
| Androgen receptor binding | + | 0.7615 | 76.15% |
| Thyroid receptor binding | + | 0.7670 | 76.70% |
| Glucocorticoid receptor binding | + | 0.8292 | 82.92% |
| Aromatase binding | + | 0.8128 | 81.28% |
| PPAR gamma | + | 0.7951 | 79.51% |
| Honey bee toxicity | - | 0.7555 | 75.55% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | - | 0.5500 | 55.00% |
| Fish aquatic toxicity | - | 0.6235 | 62.35% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.83% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.17% | 96.61% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.91% | 98.94% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 98.74% | 95.00% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 98.59% | 94.45% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.54% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.98% | 96.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.83% | 93.56% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 97.01% | 92.38% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 96.99% | 99.77% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 96.85% | 87.16% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 96.60% | 94.66% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 96.45% | 91.19% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 96.36% | 96.47% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.12% | 98.24% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.95% | 98.10% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 95.31% | 96.67% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.19% | 100.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.96% | 96.03% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 94.55% | 95.17% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.34% | 97.09% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 94.32% | 98.89% |
| CHEMBL236 | P41143 | Delta opioid receptor | 94.08% | 99.35% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 93.91% | 97.43% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.82% | 100.00% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.41% | 100.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 92.90% | 93.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 92.79% | 97.50% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 92.65% | 96.31% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 92.50% | 94.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 92.45% | 96.67% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 92.35% | 95.38% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 92.28% | 98.05% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.13% | 97.14% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 92.03% | 97.64% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 91.95% | 92.12% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 91.57% | 90.17% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 90.86% | 95.71% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 90.71% | 88.42% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 90.65% | 96.28% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 90.49% | 97.25% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.49% | 90.08% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 90.35% | 93.33% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 90.23% | 83.14% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 90.14% | 98.77% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.95% | 99.17% |
| CHEMBL4801 | P29466 | Caspase-1 | 89.89% | 96.85% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 89.75% | 97.64% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 89.09% | 91.11% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 89.07% | 92.50% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 88.25% | 96.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 87.85% | 94.45% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 87.62% | 82.69% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 87.51% | 96.90% |
| CHEMBL3468 | P55210 | Caspase-7 | 87.50% | 95.68% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 87.16% | 97.47% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 86.80% | 94.33% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 86.79% | 98.00% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 86.37% | 97.29% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 86.19% | 81.29% |
| CHEMBL3776 | Q14790 | Caspase-8 | 85.64% | 97.06% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 85.54% | 97.50% |
| CHEMBL3105 | P09874 | Poly [ADP-ribose] polymerase-1 | 85.05% | 93.90% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 84.93% | 100.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 84.86% | 96.33% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 84.77% | 98.33% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 84.75% | 96.25% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 84.73% | 96.38% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 84.20% | 97.09% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 84.05% | 86.67% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 84.01% | 98.75% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 83.81% | 99.17% |
| CHEMBL2140 | P48775 | Tryptophan 2,3-dioxygenase | 83.73% | 98.46% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 83.00% | 97.86% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 82.77% | 92.80% |
| CHEMBL5028 | O14672 | ADAM10 | 82.73% | 97.50% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 82.62% | 97.29% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 82.61% | 95.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 82.27% | 95.89% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 81.75% | 97.23% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 81.46% | 89.63% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 81.38% | 83.10% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 80.81% | 94.50% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 80.71% | 82.38% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 80.56% | 89.50% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 80.46% | 99.23% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 80.35% | 99.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 80.35% | 95.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139586779 |
| LOTUS | LTS0235969 |
| wikiData | Q77514247 |